Covered recipient · General Payments record
MITCHELL J GOLD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2022
$1,652.16
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $380.40 | 30 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $206.64 | 18 |
| Amgen Inc. | $32.13 | 2 |
| GlaxoSmithKline, LLC. | $16.82 | 1 |
| Lilly USA, LLC | $16.06 | 1 |
| Novo Nordisk AS | $14.53 | 1 |
| EISAI INC. | $14.41 | 1 |
| Lucid Diagnostics Inc. | $14.14 | 1 |
| Currax Pharmaceuticals LLC | $13.67 | 1 |
| Acerta Pharma LLC | $13.53 | 1 |
| SHIELD THERAPEUTICS INC | $13.26 | 1 |
| Horizon Pharma plc | $12.93 | 1 |
| Abbott Laboratories | $12.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $12.28 | 03/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920494425 | CMS |
| ABBVIE INC. | $15.60 | 01/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047755 | CMS |
| ABBVIE INC. | $1.74 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047757 | CMS |
| ABBVIE INC. | $12.23 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047759 | CMS |
| ABBVIE INC. | $5.61 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047761 | CMS |
| ABBVIE INC. | $22.92 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047763 | CMS |
| ABBVIE INC. | $7.43 | 05/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047765 | CMS |
| ABBVIE INC. | $13.78 | 06/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047767 | CMS |
| ABBVIE INC. | $12.29 | 06/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047769 | CMS |
| ABBVIE INC. | $4.73 | 06/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047771 | CMS |
| ABBVIE INC. | $19.10 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047773 | CMS |
| ABBVIE INC. | $6.14 | 07/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047775 | CMS |
| ABBVIE INC. | $16.82 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047777 | CMS |
| ABBVIE INC. | $16.28 | 07/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047779 | CMS |
| ABBVIE INC. | $6.44 | 08/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047781 | CMS |
| ABBVIE INC. | $19.18 | 10/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047783 | CMS |
| ABBVIE INC. | $9.48 | 11/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047785 | CMS |
| ABBVIE INC. | $8.90 | 12/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047787 | CMS |
| ABBVIE INC. | $7.97 | 12/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891047789 | CMS |
| Amgen Inc. | $14.42 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939475173 | CMS |
| Amgen Inc. | $17.71 | 10/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939475175 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.53 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920260515 | CMS |
| Currax Pharmaceuticals LLC | $13.67 | 05/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 925771721 | CMS |
| EISAI INC. | $14.41 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908067095 | CMS |
| GlaxoSmithKline, LLC. | $16.82 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944581219 | CMS |
| Horizon Therapeutics plc | $12.93 | 01/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 937625609 | CMS |
| Lilly USA, LLC | $16.06 | 07/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918270001 | CMS |
| Lucid Diagnostics Inc. | $14.14 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 962719815 | CMS |
| Novo Nordisk Inc | $14.53 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898981057 | CMS |
| Shield Therapeutics Inc | $13.26 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 946409399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.